Vertex Pharmaceuticals (VRTX)
New Form 8-K - VERTEX PHARMACEUTICALS INC / MA Filed: 2025-08-04 AccNo: 0000875320-25-000213 Size: 422 KB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Inovio Pharmaceuticals Inc (INO)
Inovio - INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025
Clearpoint Neuro Inc (CLPT)
ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio
Altimmune Inc (ALT)
Tilray Brands Inc. (TLRY)
Tactile Systems Technology (TCMD)
Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results
89bio Inc (ETNB)
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Addus HomeCare Corporation (ADUS)
Addus HomeCare Announces Second Quarter 2025 Financial Results
CVRx Inc. (CVRX)
CVRx Reports Second Quarter 2025 Financial and Operating Results
Castle Biosciences Inc (CSTL)
Castle Biosciences - Castle Biosciences Reports Second Quarter 2025 Results
Tactile Systems Technology (TCMD)
Altimmune Inc (ALT)
Incyte Corporation (INCY)
9 Meters Biopharma, Inc. (NMTRQ)
Best Brands For Laptops in 2025